TABLE 2.

Relationship between criteria utilized in the multidimensional approach in defining innovativeness of a new medicine.

		Added therapeutic value
	n	Maximum	Important	Moderate	Poor	Absent
Therapeutic need	Maximum	1	5	4	3	0
	Important	0	12	14	6	2
	Moderate	0	15	20	16	1
	Poor	0	0	1	4	0
	Absent	0	0	0	0	0
		Therapeutic need
	n	Maximum	Important	Moderate	Poor	Absent
Quality of clinical evidence	High	1	8	9	0	0
	Moderate	4	15	38	4	0
	Low	6	11	5	0	0
	Very low	2	2	3	1	0
		Added therapeutic value
	n	Maximum	Important	Moderate	Poor	Absent
Quality of clinical evidence	High	0	6	7	3	2
	Moderate	1	17	19	20	1
	Low	0	8	8	5	0
	Very low	0	1	5	1	0

Cramer V = 0.24; p = 0.224. Cramer V = 0.25; p = 0.008. Cramer V = 0.20; p = 0.517. Data were summarized as numbers (n). Chi-squared test was used to compute the p-value for Cramer's V.